Shopping Cart 0
Cart Subtotal
AED 0

St. Georges University of London - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider. It offers undergraduate and post graduate courses. The university's undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthcare practice foundation degree, biomedical science foundation degree, breast imaging foundation degree, healthcare science and medicine MBBS. It provides post graduate courses such as biomedical science MRes, clinical practice MRes, medical imaging, nursing, oncology practice PgCert, physician associate studies postgraduate diploma, physiotherapy MSc and social work PgDip. SGUL conducts research in the field of cardiovascular and cell sciences, infection and immunity and population health. The university partners with other institutions for its research activities. SGUL is headquartered in London, England, the UK.

St. George's University of London-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

St. George's University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

St. George's University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

St. George's University of London, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Symcel Sverige Enter into Partneship with TiKa Diagnostics and St. George's University 10

DNA2.0 Enters Into Research Agreement With St George's University Of London For Production Of Therapeutic Antibodies 11

Licensing Agreements 12

Orphan Technologies Enters Into Licensing Agreement With St George's University of London For Erythrocyte Encapsulated Technology 12

St. George's University of London-Key Competitors 13

St. George's University of London-Key Employees 14

St. George's University of London-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Dec 11, 2017: Experts discover ways to tackle drug resistant parasites that cause the killer disease malaria 16

Nov 10, 2017: New hope for osteoarthritis patients suffering severe pain in hands 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

St. George's University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

St. George's University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

St. George's University of London, Pharmaceuticals & Healthcare, Key Facts 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

St. George's University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

St. George's University of London, Deals By Therapy Area, 2012 to YTD 2018 8

St. George's University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Symcel Sverige Enter into Partneship with TiKa Diagnostics and St. George's University 10

DNA2.0 Enters Into Research Agreement With St George's University Of London For Production Of Therapeutic Antibodies 11

Orphan Technologies Enters Into Licensing Agreement With St George's University of London For Erythrocyte Encapsulated Technology 12

St. George's University of London, Key Competitors 13

St. George's University of London, Key Employees 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

St. George's University of London, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider. It offers undergraduate and post graduate courses. The university's undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthcare practice foundation degree, biomedical science foundation degree, breast imaging foundation degree, healthcare science and medicine MBBS. It provides post graduate courses such as biomedical science MRes, clinical practice MRes, medical imaging, nursing, oncology practice PgCert, physician associate studies postgraduate diploma, physiotherapy MSc and social work PgDip. SGUL conducts research in the field of cardiovascular and cell sciences, infection and immunity and population health. The university partners with other institutions for its research activities. SGUL is headquartered in London, England, the UK.

St. George's University of London-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

St. George's University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

St. George's University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

St. George's University of London, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Symcel Sverige Enter into Partneship with TiKa Diagnostics and St. George's University 10

DNA2.0 Enters Into Research Agreement With St George's University Of London For Production Of Therapeutic Antibodies 11

Licensing Agreements 12

Orphan Technologies Enters Into Licensing Agreement With St George's University of London For Erythrocyte Encapsulated Technology 12

St. George's University of London-Key Competitors 13

St. George's University of London-Key Employees 14

St. George's University of London-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Dec 11, 2017: Experts discover ways to tackle drug resistant parasites that cause the killer disease malaria 16

Nov 10, 2017: New hope for osteoarthritis patients suffering severe pain in hands 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

St. George's University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

St. George's University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

St. George's University of London, Pharmaceuticals & Healthcare, Key Facts 2

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

St. George's University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

St. George's University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

St. George's University of London, Deals By Therapy Area, 2012 to YTD 2018 8

St. George's University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Symcel Sverige Enter into Partneship with TiKa Diagnostics and St. George's University 10

DNA2.0 Enters Into Research Agreement With St George's University Of London For Production Of Therapeutic Antibodies 11

Orphan Technologies Enters Into Licensing Agreement With St George's University of London For Erythrocyte Encapsulated Technology 12

St. George's University of London, Key Competitors 13

St. George's University of London, Key Employees 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

St. George's University of London, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.